Kohl’s calls on shareholders to reject activist Macellum’s proposal ahead of annual meeting

Kohl’s calls on shareholders to reject activist Macellum’s proposal ahead of annual meeting


People shop at Kohl’s department store amid the coronavirus outbreak on September 5, 2020 in San Francisco, California.

Liu Guanguan | China News Service | Getty Images

Kohl’s on Thursday sent a letter to shareholders in which it pushed back against activist investor Macellum’s campaign to add new directors to the retailer’s board.

In the letter, which comes ahead of Kohl’s annual meeting with shareholders in May, the retailer called Macellum’s nominees an “unqualified slate.”

“Macellum is promoting an ever-changing narrative, misinformed claims, and value-destructive proposals, all of which reveal a reckless and short-term approach that is not in the interest of driving long-term, sustainable value,” Kohl’s said.

A representative for Macellum didn’t immediately respond to CNBC’s request for comment.

Macellum, led by veteran retail-industry investor Jonathan Duskin, amplified its pressure on Kohl’s in February, following months-long criticisms of the big-box retailer for not performing as well as it could in 2021. It nominated 10 directors, including Duskin himself. That came after the activist called for Kohl’s to consider selling itself.

Kohl’s has since started working with bankers and other financial advisors to consider bids for its business. It has already rejected one offer from Starboard-backed Acacia Research, at $64 per share, calling it too low.

Earlier this month, it confirmed receipt of multiple preliminary buyout offers. One of those bidders is Saks Fifth Avenue owner HBC, a source familiar with the transaction previously told CNBC. HBC declined to comment.

In its letter, Kohl’s said that Macellum’s push for a “hasty sale at any price” reveals a short-term approach that isn’t in the best interest of the company’s shareholders.

Regarding its conversations with potential bidders, Kohl’s added that it is involved in further engagement with select bidders, “including assisting with further due diligence that may create opportunities to refine and improve proposals.”

Shares of Kohl’s were little changed in premarket trading.

Find the full letter sent to Kohl’s shareholders here.

This story is developing. Please check back for updates.



Source

The  million Trump Card faces legal challenges, limited market
Business

The $5 million Trump Card faces legal challenges, limited market

U.S. President Donald Trump holds “The Trump Card” as he speaks with journalists onboard Air Force One en route to Miami, Florida, U.S., April 3, 2025. Kent Nishimura | Reuters A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to […]

Read More
Nike will report earnings after the bell. Here’s what Wall Street expects
Business

Nike will report earnings after the bell. Here’s what Wall Street expects

A shopper walks past a Nike store, as global markets brace for a hit to trade and growth caused by U.S. President Donald Trump’s decision to impose import tariffs on dozens of countries, in the King of Prussia Mall in King of Prussia, Pennsylvania, U.S., April 3, 2025.  Rachel Wisniewski | Reuters Nike is expected […]

Read More
RFK Jr.’s CDC vaccine panel backs Merck RSV shot for infants
Business

RFK Jr.’s CDC vaccine panel backs Merck RSV shot for infants

Nikos Pekiaridis | Nurphoto | Getty Images Robert F. Kennedy Jr.’s revamped government panel of outside vaccine advisors on Thursday recommended the use of Merck‘s shot to protect infants from respiratory syncytial virus, a temporary reprieve for public health officials and companies concerned about the Health and Human Services secretary’s immunization policy. The group, called […]

Read More